Get started
Author

Bernardo Lozano-Dubernard

Observed names: B. Lozano-Dubernard, Lozano-Dubernard, Bernardo
ORCID: 0009-0009-6430-7080
Observed ORCID: 0009-0009-6430-7080
OpenAlex ID: A5000925477
Origins of the 2009 H1N1 influenza pandemic in swine in Mexico
2016 · Ignacio Mena, Martha I Nelson, et al. · eLife · 368
Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico
2023 · Samuel Ponce-de-León, Martha Torres, et al. · npj Vaccines · 72
PDF
Protective Dose of a Recombinant Newcastle Disease LaSota–Avian Influenza Virus H5 Vaccine Against H5N2 Highly Pathogenic Avian Influenza Virus and Velogenic Viscerotropic Newcastle Disease Virus in Broilers with High Maternal Antibody Levels
2010 · David Sarfati-Mizrahi, Bernardo Lozano-Dubernard, et al. · Avian Diseases · 48
Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs
2021 · Jesús Horacio Lara-Puente, Juan Manuel Carreño, et al. · mBio · 46
Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine
2016 · Nuriban Valero-Pacheco, Marisol Pérez-Toledo, et al. · PLoS ONE · 29
PDF
Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 “Patria” recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico
2024 · Constantino López-Macías, Martha Torres, et al. · Vaccine · 18
Protection and Differentiation of Infected from Vaccinated Animals by an Inactivated Recombinant Newcastle Disease Virus/Avian Influenza H5 Vaccine
2010 · Bernardo Lozano-Dubernard, Ernesto Soto-Priante, et al. · Avian Diseases · 11
La Piedad Michoacán Mexico Virus V protein antagonizes type I interferon response by binding STAT2 protein and preventing STATs nuclear translocation
2015 · Giuseppe Pisanelli, Maudry Laurent-Rolle, et al. · Virus Research · 9
Phase 2/3 study evaluating safety, immunogenicity, and noninferiority of single booster dose of AVX/COVID-12 vaccine
2025 · Constantino López-Macías, Martha Torres, et al. · Science Advances · 6
PDF
Efficacy of an intranasally administered live attenuated PRRSV-2 vaccine against challenge with a highly virulent PRRSV-1 strain
2025 · E. Mateu, M. Cortey, et al. · Frontiers in Veterinary Science · 5
PDF
Author response: Origins of the 2009 H1N1 influenza pandemic in swine in Mexico
2016 · Ignacio Mena, Martha I Nelson, et al. · eLife · 5
Addressing SARS-CoV-2 evolution: neutralization of emerging variants of concern by the AVX/COVID-12 ‘Patria’ vaccine based on HexaPro-S ancestral Wuhan spike or its updated BA.2.75.2 version
2025 · Gregorio Carballo-Uicab, Gabriela Mellado-Sánchez, et al. · Frontiers in Immunology · 3
PDF
The Validation of a Hemagglutination Inhibition Assay That Detects Antibodies Against a Newcastle Disease Virus-Based Vaccine Vector in Human Serum Samples
2025 · Milton Nieto-Ponce, Edgar Reyna-Rosas, et al. · Vaccines · 3
Newcastle disease virus vector-based SARS-CoV-2 vaccine candidate AVX/COVID-12 activates T cells and is recognized by antibodies from COVID-19 patients and vaccinated individuals
2024 · Alejandro Torres-Flores, Luis Alberto Ontiveros-Padilla, et al. · Frontiers in Immunology · 3
Protective Efficacy of an Inactivated H5N8 Avian Influenza Virus Vaccine Against Highly Pathogenic Avian Influenza H5N1 Viruses Belonging to Clade 2.3.4.4b in Chickens and Ducks
2025 · Luis Ramírez-Martínez, Francesco Bonfante, et al. · Avian Diseases · 2
Phase II/III Double-Blind Study Evaluating Safety and Immunogenicity of a Single Intramuscular Booster Dose of the Recombinant SARS-CoV-2 Vaccine “Patria” (AVX/COVID-12) Using an Active Newcastle Disease Viral Vector (NDV) during the Omicron Outbreak in Healthy Adults with Elevated Baseline Antibody Titers from Prior COVID-19 and/or SARS-CoV-2 Vaccination
2024 · Constantino López-Macías, Martha Torres, et al. · medRxiv · 2
PDF
Protective Dose of a Recombinant Newcastle Disease Lasota–Avian Influenza Virus H5 Vaccine Against H5N2 Highly Pathogenic Avian Influenza Virus and Velogenic Viscerotropic Newcastle Disease Virus in Broilers with High Maternal Antibody Levels
2010 · David Sarfati-Mizrahi, Bernardo Lozano-Dubernard, et al. · Avian Diseases Digest · 1
Protection and Differentiation of Infected from Vaccinated Animals by an Inactivated Recombinant Newcastle Disease Virus/Avian Influenza H5 Vaccine
2010 · Bernardo Lozano-Dubernard, Ernesto Soto-Priante, et al. · Avian Diseases Digest · 1
Works count: 28
Citation count: 632
H-index: 8
I10-index: 7
Year
Topic
Type